Breaking News

Harlan Labs Appoints BD Director

By Kristin Brooks | February 4, 2014

Guptato to head RMS Business Unit

Urvashi Gupta has been appointed director of business development for Harlan Laboratories Research Models and Services (RMS) business unit in Asia. Ms. Gupta will focus on expanding Harlan's market position and new business initiatives, including key strategic partnerships and leading corporate development efforts. She will also oversee a team of business development managers in Japan and Korea, and will have responsibility for agents in China, Singapore, Hong Kong, Malaysia and Australia.
 
Ms. Gupta has 13 years of experience in research, operations, client relations and sales throughout Asia, Europe and the U.S. Most recently, she served as business development manager for Covance, where she was responsible for all sales initiatives in India with a focus on expanding the company's presence throughout the region. She also worked as an operations manager and research scientist with Covance.

"As the preclinical research market continues to establish roots and grow outside of North America and Europe, now is the perfect time to expand our already talented business development group," said Stuart Frith, global vice president of business development at Harlan Laboratories. "We're excited to add Urvashi to our team, and her wealth of international experience in the CRO and pharmaceutical industries will be an asset to Harlan as we continue to expand in Asia."  
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision